XML 53 R42.htm IDEA: XBRL DOCUMENT v3.25.2
Basis of Presentation and Significant Accounting Policies (Details Narrative)
2 Months Ended 3 Months Ended 12 Months Ended
Jul. 31, 2025
USD ($)
shares
Jul. 31, 2025
USD ($)
Jul. 31, 2024
shares
Apr. 30, 2025
USD ($)
Apr. 30, 2024
Aug. 31, 2025
USD ($)
Jul. 31, 2025
CAD ($)
Jun. 06, 2025
USD ($)
Apr. 30, 2025
CAD ($)
Product Information [Line Items]                  
Net cash used in operating activities $ 1,725,439                
Cash 3,019,711 $ 3,019,711              
Working capital deficit 1,000,000 1,000,000              
CDIC insured amount                 $ 100,000
CDIC Uninsured amount             $ 3,511,000    
FDIC insured amount 250,000 250,000              
FDIC Uninsured amount 153,000 153,000              
Allowance for doubtful accounts $ 86,000 $ 86,000   $ 0          
Finite lived intangible asset useful life 10 years 10 years         10 years    
2026 $ 388,306 $ 388,306              
2027 523,543 523,543              
2028 523,543 523,543              
2029 523,543 523,543              
2030 523,543 523,543              
Thereafter 2,674,065 2,674,065              
Allowance for doubtful accounts 1,000 1,000   0          
Contract assets 233,274 233,274   0          
Contract with customer liability current 433,122 433,122   0          
Revenue remaining performance obligation 630,000 $ 630,000           $ 726,000  
Product warranty description   The Company (Successor) assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company’s warranty policy, an accrual is established at 1% of the trailing 18 months revenue.              
Accrued warranty reserve amount $ 49,124 $ 49,124   $ 0          
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer One [Member]                  
Product Information [Line Items]                  
Concentration risk percentage 53.00%                
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer Two [Member]                  
Product Information [Line Items]                  
Concentration risk percentage 23.00%                
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer Three [Member]                  
Product Information [Line Items]                  
Concentration risk percentage 10.00%                
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer One [Member]                  
Product Information [Line Items]                  
Concentration risk percentage 52.00%     57.00%          
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer Two [Member]                  
Product Information [Line Items]                  
Concentration risk percentage 26.00%       33.00%        
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer Three [Member]                  
Product Information [Line Items]                  
Concentration risk percentage 10.00%       10.00%        
Minimum [Member]                  
Product Information [Line Items]                  
Revenue remaining performance obligation               $ 96,000  
Convertible Debt Securities [Member]                  
Product Information [Line Items]                  
Potentially dilutive equity instruments outstanding | shares 1,085,621   0            
Warrant [Member]                  
Product Information [Line Items]                  
Potentially dilutive equity instruments outstanding | shares 496,803   0            
Restricted Stock [Member]                  
Product Information [Line Items]                  
Potentially dilutive equity instruments outstanding | shares 524,999   0            
Share-Based Payment Arrangement [Member]                  
Product Information [Line Items]                  
Potentially dilutive equity instruments outstanding | shares 39,174   0            
Equity Unit Purchase Agreements [Member]                  
Product Information [Line Items]                  
Potentially dilutive equity instruments outstanding | shares 24,645   0            
Private Investment Public Equity [Member] | Subsequent Event [Member]                  
Product Information [Line Items]                  
Private investment in public equity, amount           $ 500,000,000